TGFB1 and cancer: Given the aforementioned role of TGF-β as a released factor promoting cancer proliferation, it is not surprising that TGF-β inhibitors represent another class of novel molecules utilized to prevent bone metastases, blocking the vicious cycle between cancer cells and the bone (Buijs et al., 2012; Hu et al., 2012; Wan et al., 2012).